These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15864069)

  • 1. Evidence for PTZ-like cues as a function of time following treatment with chlordiazepoxide: implications for understanding tolerance and withdrawal.
    Barrett RJ; Smith RL
    Behav Pharmacol; 2005 May; 16(3):147-53. PubMed ID: 15864069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal.
    Barrett RJ; Caul WF; Smith RL
    Pharmacol Biochem Behav; 2004 Dec; 79(4):761-71. PubMed ID: 15582685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat.
    Broersen LM; Abbate F; Feenstra MG; de Bruin JP; Heinsbroek RP; Olivier B
    Psychopharmacology (Berl); 2000 May; 149(4):366-76. PubMed ID: 10867964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The discriminative stimulus properties of ethanol and acute ethanol withdrawal states in rats.
    Gauvin DV; Harland RD; Criado JR; Michaelis RC; Holloway FA
    Drug Alcohol Depend; 1989 Oct; 24(2):103-13. PubMed ID: 2791886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chlordiazepoxide/pentylenetetrazol discrimination: characterization of drug interactions and homeostatic responses to drug challenges.
    Michaelis RC; Holohean AM; Criado JR; Harland RD; Hunter GA; Holloway FA
    Psychopharmacology (Berl); 1988; 96(1):15-20. PubMed ID: 3147473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of tolerance development to benzodiazepines in antagonism of the pentylenetetrazol discriminative stimulus.
    Shearman GT; Miksic S; Lal H
    Pharmacol Biochem Behav; 1979 May; 10(5):795-7. PubMed ID: 40253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cue dimensionality in the three-choice pentylenetetrazole-saline-chlordiazepoxide discrimination task.
    Gauvin DV; Holloway FA
    Behav Pharmacol; 1991 Nov; 2(4 And 5):417-428. PubMed ID: 11224084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalization between benzodiazepine- and triazolopyridazine-elicited discriminative cues.
    McElroy JF; Feldman RS
    Pharmacol Biochem Behav; 1982 Oct; 17(4):709-13. PubMed ID: 6294680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone.
    Gauvin DV; Peirce JM; Holloway FA
    Pharmacol Biochem Behav; 1994 Jan; 47(1):153-9. PubMed ID: 8115417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-carbolines with agonistic and inverse agonistic properties at benzodiazepine receptors of the rat.
    Stephens DN; Kehr W; Schneider HH; Schmiechen R
    Neurosci Lett; 1984 Jun; 47(3):333-8. PubMed ID: 6089053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drug discrimination history on anti-punishment properties of chlordiazepoxide in rats.
    Pattij T; Hijzen TH; Gommans J; Maes RA; Olivier B
    Pharmacol Biochem Behav; 2000 Nov; 67(3):621-7. PubMed ID: 11164094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional attenuation of the antipentylenetetrazol activity of chlordiazepoxide.
    Taukulis HK
    Pharmacol Biochem Behav; 1993 Oct; 46(2):467-71. PubMed ID: 7903461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors.
    Stephens DN; Shearman GT; Kehr W
    Psychopharmacology (Berl); 1984; 83(3):233-9. PubMed ID: 6089245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal from chronic haloperidol substitutes for the pentylenetetrazol discriminative stimulus.
    Bronson ME
    Life Sci; 1993; 52(16):PL129-33. PubMed ID: 8464331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of pentylenetetrazol and bemegride: some generalization and antagonism tests.
    Shearman G; Lal H
    Psychopharmacology (Berl); 1979 Sep; 64(3):315-9. PubMed ID: 41279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chlordiazepoxide training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure.
    De Vry J; Slangen JL
    Psychopharmacology (Berl); 1986; 88(2):177-83. PubMed ID: 3006110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the actions of trimethadione and chlordiazepoxide in animal models of anxiety and benzodiazepine receptor binding.
    Bennett DA; Geyer H; Dutta P; Brugger S; Fielding S; Lal H
    Neuropharmacology; 1982 Nov; 21(11):1175-9. PubMed ID: 6129593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task.
    Barrett RJ; Caul WF; Smith R
    Pharmacol Biochem Behav; 2005 May; 81(1):1-8. PubMed ID: 15894057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.